-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives $32.29 Average Target Price from Analysts
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have been given an average rating of “Buy” by the eight analysts that are currently covering the firm, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have been given an average rating of “Buy” by the eight analysts that are currently covering the firm, Marketbeat reports. Seven investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
